Compare FMC Corp (FMC) vs UnitedHealth Group Inc (UNH) Price & Performance

FMC Corporation (NYSE: FMC) trades at $8.695, down 4.35% today, reflecting ongoing challenges in the agricultural chemicals sector. The stock shows bearish technical signals with mixed earnings performance - beating Q1 and Q2 2026 estimates but missing Q4 2025. Fundamentally, the company faces significant headwinds with a net income margin of -84.83% and negative ROE of -91.47%, though valuation metrics like P/S of 0.34 and P/B of 0.85 suggest potential undervaluation. Recent developments include regulatory submissions for new herbicides in Brazil and a minority equity investment from Tessenderlo Group.

The investment outlook remains cautious despite analyst consensus pointing to 68% upside potential with a $14.60 price target. While aggressive deleveraging efforts and new product pipelines offer potential catalysts, substantial earnings losses, volatile cash flows, and high debt levels present significant risks. The agricultural sector's cyclical nature and pricing pressures require careful monitoring of the company's turnaround execution and market conditions.

UnitedHealth Group (UNH) trades at $375.98, showing minor daily weakness but maintaining a bullish technical signal. The company reported strong Q2 2026 earnings, beating estimates, and reaffirmed its full-year outlook. Revenue growth remains robust, though net margins have compressed from prior years. Analyst sentiment is overwhelmingly positive, with a consensus price target of $473.89 implying significant upside.

The outlook for UNH is favorable, driven by earnings momentum and strategic initiatives like AI investment. Key risks include regulatory pressures and medical cost trends. The stock presents a compelling opportunity for investors seeking exposure to a leading healthcare company with solid fundamentals and Wall Street support.